HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Combination chemotherapy of MCNU and interferon alfa-2a (genetical recombination) for advanced multiple myeloma].

AuthorsN Hino, W Matsuura, K Kawakami, T Ono, T Matsumoto, T Tominaga
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 17 Issue 4 Pt 1 Pg. 693-6 (Apr 1990) ISSN: 0385-0684 [Print] Japan
PMID2321988 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Interferon Type I
  • Interferon alpha-2
  • Interferon-alpha
  • Nitrosourea Compounds
  • Recombinant Proteins
  • ranimustine
Topics
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents (administration & dosage, therapeutic use)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Humans
  • Interferon Type I (administration & dosage)
  • Interferon alpha-2
  • Interferon-alpha (administration & dosage, therapeutic use)
  • Male
  • Middle Aged
  • Multiple Myeloma (therapy)
  • Nitrosourea Compounds (administration & dosage, therapeutic use)
  • Recombinant Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: